Viridian Therapeutics (VRDN) Stock Chart & Stock Price History $17.05 +0.26 (+1.55%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$17.04 -0.01 (-0.06%) As of 07/17/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viridian Therapeutics Stock Price Performance The Viridian Therapeutics (VRDN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 17.83%, with a year-to-date return of -11.06%. In the past month, the stock has increased 13.67%, reflecting recent market activity. As of the latest close, Viridian Therapeutics traded at $17.05 with a market cap of $1.39 billion and volume of 419,240 shares. Receive VRDN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.06%1 Month Performance+13.67%3 Month Performance+29.86%Year-To-Date Performance-11.06%1 Year Performance+17.83% VRDN Stock Chart for Friday, July, 18, 2025 VRDN Chart by TradingView Viridian Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$16.79$17.05+1.55%$17.26$16.83419,240 shs$1.39 billion07/16/2025$16.26$16.79+3.26%$17.10$16.42585,392 shs$1.37 billion07/15/2025$17.14$16.26-5.13%$17.34$15.97670,249 shs$1.33 billion07/14/2025$17.04$17.14+0.59%$17.48$16.931.02 million shs$1.40 billion07/11/2025$17.13$17.04-0.53%$17.39$16.78477,598 shs$1.39 billion07/10/2025$17.04$17.13+0.53%$17.32$16.66556,531 shs$1.40 billion07/09/2025$16.05$17.04+6.17%$17.53$16.12938,826 shs$1.39 billion07/08/2025$15.89$16.05+1.01%$16.27$15.69807,335 shs$1.31 billion07/07/2025$15.59$15.89+1.96%$16.07$15.36935,231 shs$1.30 billion07/04/2025$15.59$15.59$15.94$14.98396,663 shs$1.27 billion Get the Latest News and Ratings for VRDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$15.23$15.59+2.33%$15.94$14.98396,663 shs$1.27 billion07/02/2025$14.47$15.23+5.25%$15.59$14.33896,253 shs$1.24 billion07/01/2025$13.98$14.47+3.51%$14.91$13.84825,273 shs$1.18 billion06/30/2025$14.33$13.98-2.44%$14.71$13.92470,330 shs$1.14 billion06/27/2025$14.55$14.33-1.51%$14.79$14.221.28 million shs$1.17 billion06/26/2025$14.70$14.55-1.02%$14.85$14.24464,486 shs$1.19 billion06/25/2025$14.66$14.70+0.27%$14.84$14.11560,604 shs$1.20 billion06/24/2025$14.71$14.66-0.34%$15.00$14.43551,586 shs$1.20 billion06/23/2025$14.72$14.71-0.07%$15.02$14.48536,543 shs$1.20 billion06/20/2025$15.00$14.72-1.87%$15.25$14.441.47 million shs$1.20 billion06/19/2025$15.00$15.00$15.35$14.53530,885 shs$1.22 billion06/18/2025$14.84$15.00+1.08%$15.35$14.53530,885 shs$1.22 billion06/17/2025$15.94$14.84-6.90%$15.84$14.31806,220 shs$1.21 billion Related Companies OPCH Stock Chart RDNT Stock Chart BTSG Stock Chart SHC Stock Chart SGRY Stock Chart PRVA Stock Chart CON Stock Chart WGS Stock Chart VCYT Stock Chart ADUS Stock Chart Receive VRDN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRDN) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRDN Stock Alerts